Michigan Laws 333.9707 – Functions
Current as of: 2024 | Check for updates
|
Other versions
The committee shall be advisory in nature and shall assist the department with the following functions pursuant to applicable state and federal law:
(a) Advise and make recommendations to the department for the inclusion of prescription drugs on the preferred drug list based on available information regarding the known potential impact on patient care, the known potential fiscal impact on related medicaid covered services, and sound clinical evidence found in labeling, drug compendia, and peer-reviewed literature pertaining to use of the drug in the relevant population.
Terms Used In Michigan Laws 333.9707
- Committee: means the Michigan pharmacy and therapeutics committee established by Executive Order No. See Michigan Laws 333.9701
- Drug: means that term as defined in section 17703. See Michigan Laws 333.9701
- Evidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other.
- Initiative: means the pharmaceutical best practices initiative established by this part. See Michigan Laws 333.9701
- Medicaid: means the program of medical assistance established under title XIX of the social security act, 42 USC 1396 to 1396w-5. See Michigan Laws 333.9701
- Prescription: means that term as defined in section 17708. See Michigan Laws 333.9701
- Prescription drug: means that term as defined in section 17708. See Michigan Laws 333.9701
- state: when applied to the different parts of the United States, shall be construed to extend to and include the District of Columbia and the several territories belonging to the United States; and the words "United States" shall be construed to include the district and territories. See Michigan Laws 8.3o
(b) Advise the department on issues affecting prescription drug coverage for the department’s various health care programs.
(c) Recommend to the department guidelines for prescription drug coverage under the department’s various health care programs.
(d) Develop a process to collect and review information about new prescription drugs. The department shall post this process and the necessary forms on the department’s website.
(e) Recommend to the department strategies to improve the initiative.